Skip to main content
MeVis Medical Solutions AG logo

MeVis Medical Solutions AG — Investor Relations & Filings

Ticker · M3V ISIN · DE000A0LBFE4 LEI · 529900Z8B6L1WCLNHW14 BE Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 490 across all filing types
Latest filing 2026-05-21 Earnings Release
Country DE Germany
Listing BE M3V

About MeVis Medical Solutions AG

https://www.mevis.de/en/

MeVis Medical Solutions AG is a developer and provider of software for image-based medical diagnostics and therapy. The company creates innovative solutions for the analysis and processing of image data, focusing on the early detection and diagnosis of diseases, particularly in oncology. Its clinical applications target breast, lung, liver, and neurological conditions. The software supports various imaging modalities, including magnetic resonance tomography (MRT), computed tomography (CT), digital mammography, tomosynthesis, and digital sonography. MeVis markets its products to manufacturers of medical devices and medical IT platforms, offering support throughout the product lifecycle from development to integration and quality assurance. The company also provides technical visualizations for professional education, research, and publication.

Recent filings

Filing Released Lang Actions
MeVis Medical Solutions AG: Half-Year Results and Forecast Adjustment for Fiscal Year 2025/2026
Earnings Release Classification · 91% confidence The document is an ad‐hoc MAR disclosure announcing MeVis Medical Solutions AG’s first half (H1) financial results (revenue and EBIT) and an updated full‐year forecast. It contains key performance highlights rather than a full set of interim financial statements. Thus, it functions as an initial earnings release for the half‐year period rather than the full interim report itself. H1 2026
2026-05-21 English
MeVis Medical Solutions AG: Bekanntmachung der Einberufung zur Hauptversammlung am 19.03.2026 in Bremen mit dem Ziel der europaweiten Verbreitung gema 121 AktG
AGM Information Classification · 99% confidence The document is an official 'Einberufung zur Hauptversammlung' (Notice of Annual General Meeting) for MeVis Medical Solutions AG. It details the agenda, proposed resolutions, board member nominations, and participation instructions for the upcoming AGM on March 19, 2026. While it contains proxy-related information, it is primarily the formal convocation notice for the meeting itself, which falls under the Proxy Solicitation & Information Statement category as it provides the necessary materials for shareholders to vote.
2026-02-06 German
MeVis veroffentlicht Zahlen fur das Geschaftsjahr 2024/2025 und Prognose fur 2025/2026
Earnings Release Classification · 100% confidence The document is a corporate news release issued by MeVis Medical Solutions AG on January 29, 2026. It provides a summary of key financial highlights (revenue, EBIT, net income) for the fiscal year 2024/2025 and includes forward-looking guidance for 2025/2026. It is clearly an initial announcement of financial results rather than the full annual report itself. According to the filing definitions, this fits the 'Earnings Release' (ER) category, as it focuses on key highlights and management commentary regarding performance and outlook. FY 2025
2026-01-29 German
Completamento conversione tranche 5 del POC
Share Issue/Capital Change Classification · 95% confidence The document is a press release from Mevim S.p.A. announcing the conversion of a convertible bond (POC) into new ordinary shares. This action directly impacts the company's capital structure and share count. According to the filing definitions, announcements regarding new share issues or capital changes fall under the 'SHA' category. While it mentions the conversion, it is a specific corporate action announcement rather than a general regulatory filing or a report publication announcement.
2026-01-14 Italian
Report Publication Announcement 2026
Report Publication Announcement Classification · 100% confidence The document is a short announcement (2123 characters) from MeVis Medical Solutions AG regarding the upcoming publication dates of their annual and half-year financial reports. It explicitly states it is a 'Preliminary announcement of the publication of financial reports' and provides the dates and links for future disclosures. Per the 'Menu vs Meal' rule, this is an announcement of a report, not the report itself, making it a Report Publication Announcement (RPA).
2026-01-05 English
Hinweis auf Jahresfinanzbericht vom 01.10.2024 bis zum 30.09.2025
Report Publication Announcement Classification · 100% confidence The document is a short notification (779 characters) informing shareholders that the annual financial report for the period 01.10.2024 to 30.09.2025 is available on the company's website. It does not contain the report itself, but rather acts as a formal announcement of its publication. Per the 'Menu vs Meal' rule, this is classified as a Report Publication Announcement (RPA).
2026-01-05 German

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.